Growing,Prevalence,Diseases,Sh health Growing Prevalence of Diseases to Shape Europe Molecular Dia
If the vagina is not offering the firm grip to your male partner, he expresses displeasure in lovemaking. You need to tighten the orifice and regain lost elasticity. You can make use of herbal remedies for loose vagina treatment naturally. H The technology behind listening devices has improved dramatically in recent years, giving new hope to those with impairment. While still far from a perfect replacement for the natural ability to hear, these devices give those with a disabili
According to a new market report published by Transparency Market Research “Molecular Diagnostics Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” the Europe molecular diagnostics market was valued at US$ 1.6 billion in 2014 and is estimated to reach US$ 4.2 billion by 2023 at a CAGR of 11.4% from 2015 to 2023.Get a Free Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=9434 Molecular diagnostics aids in early detection of various chronic infectious diseases, cancer, inherited and non-inherited disorders. Growing prevalence of hospital acquired infections and increasing unhealthy lifestyle of the population in Europe is driving the growth of molecular diagnostics market in the region. In addition, technological advancement in the field of molecular techniques, nanotechnology and proteomics is also propelling the growth of molecular diagnostics market in Europe.The Europe molecular diagnostics market is categorized on the basis of technology: polymerase chain reaction, hybridization (ISH AND FISH), mass spectrometry, transcription mediated amplification (TMA), next generation sequencing, biochips and microfluidics, others which includes nanotechnology and proteomics. The polymerase chain reaction segment dominated the Europe molecular diagnostics market in 2014. Factors such as cost-effectiveness, and acceptance of polymerase chain reaction over various other technologies contributed towards the growth of market segment. The next generation sequencing segment is expected to register the fastest growth during the forecast period due to high-throughput functional genomic research. The next generation sequencing technology finds its application in whole-genome sequencing, targeted resequencing, discovery of transcription factor binding sites, and noncoding RNA expression profiling.Based on application, the Europe molecular diagnostics market has been segmented into seven types: oncology, infectious disease testing, genomics, blood screening, women's health, microbiology, and prenatal and newborn screening. Infectious disease testing held the largest market share in 2014 due to increasing incidence of chronic infectious diseases in Europe. Furthermore, increasing infections due to environmental pollution, and growing unhealthy lifestyles among the global population also contributed towards the growth of the infectious disease testing market. The Europe molecular diagnostics market exhibits intense competition among the existing players. The market is fragmented, characterized by the presence of both established as well as emerging companies. Major players operating in the Europe molecular diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, QIAGEN N.V., Hologic, Inc., Cepheid, Inc., Siemens AG, Alere. Inc., BioMerieux, Bio-Rad Laboratories, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., and others.Full Research Report on Europe Molecular Diagnostics Market: http://www.transparencymarketresearch.com/europe-molecular-diagnostics-market.html
Growing,Prevalence,Diseases,Sh